Document is current

Article History

Received: 5 February 2025

Accepted: 16 April 2025

First Online: 25 April 2025

Declarations

:

: All strategies conducted in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later modifcations or comparable ethical standards. This study was approved by the Medical Ethics Committee of Jinling Hospital, with the approval number: 2022DZGZR-012. We examined the impact of a high-glucose environment on the physiological parameters of red blood cells derived from the voluntary blood donors through in vitro experiments, and written informed consent of the voluntary blood donors was obtained. In addition, in studies involving retrospective data analysis, written informed consent from patients was not obtained because this study is a secondary analysis of the data collected routinely for the purpose of evaluating the association between hyperglycemia and peripheral blood physiological parameters. Our research did not disclose any results related to the patient’s personal identification information.

: The authors declare no competing interests.

: Not Applicable.